We are live on
!
Find out more
CI
Capital International Portfolio holdings
AUM
$3.06B
1-Year Est. Return
33.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.82%
1 Year Est. Return
+33.84%
3 Year Est. Return
+147.42%
5 Year Est. Return
+199.93%
10 Year Est. Return
+1,048%
AUM
$1.62B
AUM Growth
–
Cap. Flow
+$1.63B
Cap. Flow
% of AUM
100.36%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
161
New
161
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$129M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$67.1M |
| 3 |
Goldman Sachs
GS
|
+$50.7M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$46.1M |
| 5 |
Halliburton
HAL
|
+$45.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.64% |
| 2 | Financials | 14.03% |
| 3 | Energy | 12.45% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Communication Services | 9.36% |
Similar funds
BAM
SFS
WWM
HC
DMIC
SAM
SAG
PCM
Capital International's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital International, which disclosed 161 positions worth $1.62B. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Gilead Sciences: 2,482,000 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Financials and Energy.
- Capital International's largest Q2 2013 buy was Gilead Sciences: 2,482,000 shares worth $127M.
- Capital International's ten largest holdings make up 33% of its $1.62B portfolio in Q2 2013.
- Capital International disclosed 161 positions in Q2 2013, its first 13F filing on record.
Based on Capital International's 13F filing for Q2 2013, filed 14 Aug 2013.